title: Denial and acceptance coping styles and medication adherence in schizophrenia.
abstract: Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
authors.affiliation: Department of Psychology, University of Miami, Coral Gables, FL 33124, USA. stephanie.aldebot@umiami.edu
authors.forename: Stephanie
authors.initials: S
authors.lastname: Aldebot
authors.forename: Amy G Weisman
authors.initials: AG
authors.lastname: de Mamani
mesh_terms: D000223:Adaptation, Psychological; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D010054:Brief Psychiatric Rating Scale; D003717:Denial, Psychological; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D008016:Life Change Events; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D010342:Patient Acceptance of Health Care; D010555:Personality Inventory; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016903:Drug Monitoring
chemical_list: D014150:Antipsychotic Agents
references.citation: Schizophr Res. 2003 Jan 1;59(1):41-7
references.pmid: 12413641
references.citation: BMC Psychiatry. 2008 Apr 30;8:32
references.pmid: 18447935
references.citation: J Consult Clin Psychol. 2002 Oct;70(5):1129-39
references.pmid: 12362963
references.citation: Arch Gen Psychiatry. 1999 Mar;56(3):241-7
references.pmid: 10078501
references.citation: Psychiatr Serv. 2002 Oct;53(10):1319-21
references.pmid: 12364685
references.citation: J Psychopathol Behav Assess. 2001 Sep 1;23(3):133-143
references.pmid: 21765592
references.citation: Issues Ment Health Nurs. 2004 Apr-May;25(3):227-42
references.pmid: 14965844
references.citation: Psychol Med. 1996 Nov;26(6):1277-81
references.pmid: 8931174
references.citation: Psychiatry Res. 2006 Nov 15;144(2-3):139-52
references.pmid: 17011633
references.citation: N Engl J Med. 2005 Sep 22;353(12):1209-23
references.pmid: 16172203
references.citation: Schizophr Res. 2008 Mar;100(1-3):53-9
references.pmid: 18083007
references.citation: J Clin Psychol. 2007 Jun;63(6):593-606
references.pmid: 17457846
references.citation: Schizophr Res. 2007 Aug;94(1-3):12-22
references.pmid: 17561377
references.citation: Schizophr Bull. 1992;18(3):387-425
references.pmid: 1411329
references.citation: Schizophr Bull. 1995;21(3):395-403
references.pmid: 7481570
references.citation: Psychiatr Q. 2000 Winter;71(4):363-71
references.pmid: 11025913
references.citation: J Nerv Ment Dis. 1998 Jan;186(1):44-50
references.pmid: 9457146
references.citation: Schizophr Bull. 2007 Jan;33(1):192-9
references.pmid: 16894025
references.citation: J Pers Soc Psychol. 1989 Feb;56(2):267-83
references.pmid: 2926629
references.citation: Psychiatry Res. 1998 Jun 15;79(2):163-73
references.pmid: 9705054
references.citation: J Nerv Ment Dis. 2008 Jul;196(7):572-5
references.pmid: 18626299
references.citation: J Pers Soc Psychol. 1986 May;50(5):992-1003
references.pmid: 3712234
references.citation: Psychiatry Res. 2006 Jan 30;146(1):35-42
references.pmid: 16361089
references.citation: Am J Drug Alcohol Abuse. 2008;34(1):75-82
references.pmid: 18161645
references.citation: Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):356-63
references.pmid: 16902732
references.citation: Br J Clin Psychol. 1997 May;36(2):259-61
references.pmid: 9167865
references.citation: Aust N Z J Psychiatry. 2006 May;40(5):446-51
references.pmid: 16683971
references.citation: Compr Psychiatry. 2008 Jan-Feb;49(1):70-7
references.pmid: 18063044
references.citation: Eur Psychiatry. 1999 Sep;14(5):264-9
references.pmid: 10572356
references.citation: Schizophr Res. 2000 May 5;42(3):241-7
references.pmid: 10785582
references.citation: Bipolar Disord. 2007 Nov;9(7):737-42
references.pmid: 17988364
references.citation: Arch Gen Psychiatry. 1976 Dec;33(12):1443-6
references.pmid: 999448
references.citation: Bull Menninger Clin. 2004 Summer;68(3):231-44
references.pmid: 15342330
references.citation: Psychiatr Serv. 2007 Sep;58(9):1187-92
references.pmid: 17766564
references.citation: J Affect Disord. 2000 Sep;59(3):237-41
references.pmid: 10854641
references.citation: Hosp Community Psychiatry. 1993 Nov;44(11):1102-4
references.pmid: 8288183
references.citation: Schizophr Bull. 2008 May;34(3):483-93
references.pmid: 17932089
references.citation: J Nerv Ment Dis. 2003 Jan;191(1):38-44
references.pmid: 12544598